These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 20837075)

  • 1. Association of polymorphisms of programmed cell death-1 gene with chronic hepatitis B virus infection.
    Zhang G; Liu Z; Duan S; Han Q; Li Z; Lv Y; Chen J; Lou S; Li N
    Hum Immunol; 2010 Dec; 71(12):1209-13. PubMed ID: 20837075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of IRGM gene promoter polymorphisms on susceptibility to chronic HBV infection.
    Cheng H; Ouyang Y; Li C
    Int J Immunogenet; 2024 Jun; 51(3):149-156. PubMed ID: 38514898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between vitamin D receptor polymorphism and phases of chronic hepatitis B infection in HBV carriers in Thailand.
    Ananchuensook P; Suksawatamnauy S; Thaimai P; Sriphoosanaphan S; Thanapirom K; Teerapakpinyo C; Pooworawan Y; Komolmit P
    PLoS One; 2022; 17(12):e0277907. PubMed ID: 36490235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.
    Thio CL; Astemborski J; Bashirova A; Mosbruger T; Greer S; Witt MD; Goedert JJ; Hilgartner M; Majeske A; O'Brien SJ; Thomas DL; Carrington M
    J Virol; 2007 Jan; 81(2):441-5. PubMed ID: 17079285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of programmed cell death 1 (PD-1) gene polymorphism (rs10204525) with COVID-19 severity and mortality: A case-control study in the Iranian population.
    Mirsharif ES; Rostamian A; Salehi M; Askari N; Ghazanfari T
    Int Immunopharmacol; 2023 Jun; 119():110114. PubMed ID: 37172423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.
    Thio CL; Mosbruger TL; Kaslow RA; Karp CL; Strathdee SA; Vlahov D; O'Brien SJ; Astemborski J; Thomas DL
    J Virol; 2004 Oct; 78(20):11258-62. PubMed ID: 15452244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma.
    Boutros A; Carosio R; Campanella D; Banelli B; Morabito A; Pistillo MP; Croce E; Queirolo P; Tanda ET; Raposio E; Fontana V; Spagnolo F
    Arch Dermatol Res; 2024 Jun; 316(7):414. PubMed ID: 38880834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between polymorphisms in the PDCD1 gene and the risk of cancer: A PRISMA-compliant meta-analysis.
    Zhang J; Zhao T; Xu C; Huang J; Yu H
    Medicine (Baltimore); 2016 Oct; 95(40):e4423. PubMed ID: 27749524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B-related hepatocellular carcinoma: classification and prognostic model based on programmed cell death genes.
    Tian J; Meng J; Yang Z; Song L; Jiang X; Zou J
    Front Immunol; 2024; 15():1411161. PubMed ID: 38799437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the possible association of PDCD-1 and LAG3 gene polymorphisms with hepatocellular carcinoma risk.
    Wei J; Liao Z; Tao Y; Liu S
    BMC Med Genomics; 2023 May; 16(1):92. PubMed ID: 37131179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the Costimulatory Molecule Gene Polymorphisms (CTLA-4) Associated With Infection in Organ Transplantation? A Meta-Analysis.
    Iravani Saadi M; Jiang M; Banakar M; Mardani Valandani F; Ahmadyan M; Rostamipour HA; Kheradmand N; Noshadi N; Karimi Z; Nabi Abdolyousefi E; Ramzi M; Haghighinejad H; Yaghobi R; Hosseini F
    Cell Transplant; 2023; 32():9636897231151576. PubMed ID: 36840462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Immune-Related Adverse Events in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma Are Associated with
    Kobayashi M; Numakura K; Hatakeyama S; Muto Y; Sekine Y; Sasagawa H; Kashima S; Yamamoto R; Koizumi A; Nara T; Saito M; Narita S; Ohyama C; Habuchi T
    Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35885987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma.
    Gramantieri L; Fornari F; Giovannini C; Trerè D
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of NcRNAs to Regulate Immune Checkpoints in Cancer.
    Jiang Y; Zhao L; Wu Y; Deng S; Cao P; Lei X; Yang X
    Front Immunol; 2022; 13():853480. PubMed ID: 35464451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy against programmed death-1/programmed death ligand 1 in hepatocellular carcinoma: Importance of molecular variations, cellular heterogeneity, and cancer stem cells.
    Sukowati CHC; El-Khobar KE; Tiribelli C
    World J Stem Cells; 2021 Jul; 13(7):795-824. PubMed ID: 34367478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed cell death-1 single-nucleotide polymorphism rs10204525 is associated with human immunodeficiency virus type 1 RNA viral load in HIV-1-infected Moroccan subjects.
    Baba H; Kettani A; Bouqdayr M; Ouladlahsen A; Bensghir R; Marih L; Sodqi M; Benjelloun S; Ezzikouri S; Zaidane I; Jadid FZ; Filali KME; Wakrim L
    Med Microbiol Immunol; 2021 Aug; 210(4):187-196. PubMed ID: 34031715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression.
    Hoan NX; Huyen PTM; Binh MT; Trung NT; Giang DP; Linh BT; Dung DTN; Pallerla SR; Kremsner PG; Velavan TP; Bang MH; Song LH
    Sci Rep; 2021 Apr; 11(1):7772. PubMed ID: 33833369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases.
    De Re V; Tornesello ML; De Zorzi M; Caggiari L; Pezzuto F; Leone P; Racanelli V; Lauletta G; Zanussi S; Repetto O; Gragnani L; Rossi FM; Dolcetti R; Zignego AL; Buonaguro FM; Steffan A
    Liver Int; 2021 Jan; 41(1):133-149. PubMed ID: 32937024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of rs10204525 genotype GG and rs2227982 CC combination in programmed cell death 1 with hepatitis B virus infection risk.
    Huang C; Ge T; Xia C; Zhu W; Xu L; Wang Y; Wu F; Liu F; Zheng M; Chen Z
    Medicine (Baltimore); 2019 Aug; 98(35):e16972. PubMed ID: 31464942
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.